パチスロ 楽園
July 27, 2009
KYORIN パチスロ 楽園., Ltd. announces that its wholly owned subsidiary of KYORIN Pharmaceutical パチスロ 楽園., Ltd. ("Kyorin") (Head office: Tokyo, President: Keiji Hirai, Ph.D.) today signed a License Agreement with Senju Pharmaceutical パチスロ 楽園., Ltd. ("Senju") (Head office: Osaka, President: Yukoh Yoshida), concerning the grant of an exclusive marketing right to Senju on Gatifloxacin ophthalmic solution for China. Gatifloxacin is a broad spectrum synthetic antibacterial agent originated by Kyorin.
Please see the PDF file below for details.
